The European Cancer Congress 2013

esmo38 estro32
login
My congress planner
close
Forgot password

Create account

Flims Alumni Club Achievement Award 2013

 

 

Recipient: Jean-Charles Soria

About the Award: The Flims Alumni Club (FAC) Achievement Award recognises  scientific and clinical excellence in enhancing cancer treatment and dedication to education in oncology

Professor Jean-Charles Soria is a tenure-track and full time cancer specialist at the Institute Gustave Roussy and Professor of Medicine and Medical Oncology at Paris University XI. . He trained as a medical oncologist and obtained a Silver medal from Paris Medical School in 1997. Prof Soria gained a PhD in the fundamental basis of oncogenesis in 2001, and completed his training with a two-year post-doctoral fellowship in the Department of Thoracic Head and Neck Medical Oncology at MD Anderson Cancer Center, Houston, USA.

Prof. Soria is currently Head of the phase I programme at the Institute Gustave Roussy and a member of the lung cancer unit with a focus on targeted therapies. His main research interests are in early clinical development, phase I trials across solid tumours, pharmacodynamic biomarkers, early phase II trials and lung cancer. He is also involved in translational research aspects related to tumour progression, notably in lung cancer models. Prof Soria has been the Principal Investigator on ten phase I trials during the past three years as well as six phase II trials in lung cancer. He is currently Chair of the French Scientific National Programme on Lung Cancer (PNES), launched by the French NCI, and a member of ASCO, AACR, ESMO and IASLC.

Jean-Charles founded the Flims Alumni Club (FAC) in 2001. He is a current member of the ESMO educational committee, as well as an ASCO committee member. He is on the editorial board of the Journal of Clinical Oncology, the Lancet Oncology, the American Journal of Clinical Oncology and Bulletin du Cancer. He has contributed to over 100 peer-reviewed publications, including publications as first or last author in the New England Journal of Medicine, the Journal of the National Cancer Institute, Cancer Research and Clinical Cancer Research.

PRINT THIS PAGE